News
PBH
48.68
+0.04%
0.02
Weekly Report: what happened at PBH last week (0601-0605)?
Weekly Report · 2d ago
Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference
Barchart · 5d ago
Susan Anderson Reiterates Buy on Prestige with Unchanged $72 Price Target, Citing Overdone Weakness and Accretive Acquisitions
TipRanks · 06/02 11:51
Is Prestige Consumer Healthcare’s (PBH) Dramamine Expansion Quietly Reshaping Its OTC Brand Strength Narrative?
Simply Wall St · 06/01 20:18
These 10 mid-cap U.S. healthcare giants rank among the market's most attractively valued stocks
Seeking Alpha · 06/01 14:10
Weekly Report: what happened at PBH last week (0525-0529)?
Weekly Report · 06/01 10:19
Mid-cap healthcare stocks ranked by quant ratings after earnings season
Seeking Alpha · 05/26 14:10
Weekly Report: what happened at PBH last week (0518-0522)?
Weekly Report · 05/25 10:22
Do Prestige’s Higher Margins and New Dramamine Formats Reveal a Sharper Brand Strategy for PBH?
Simply Wall St · 05/25 00:20
Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Barchart · 05/22 16:00
Prestige Consumer Healthcare (PBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Barchart · 05/22 14:00
Prestige Consumer Healthcare, Inc. (PBH) Securities Fraud Investigation - Levi & Korsinsky
PR Newswire · 05/22 13:00
Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Barchart · 05/22 11:55
Prestige Consumer Healthcare Balances Volatility and Growth
TipRanks · 05/20 03:16
PBH Investor Alert: Levi & Korsinsky Investigates Prestige Consumer Healthcare (PBH) for Potential Securities Fraud
Barchart · 05/19 15:00
Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Barchart · 05/18 14:00
Prestige Consumer Healthcare (PBH) Valuation After Missed Q4 Targets And Delayed LaCorium Deal Disclosure
Simply Wall St · 05/18 12:23
Prestige Consumer Healthcare (PBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Barchart · 05/18 11:36
Weekly Report: what happened at PBH last week (0511-0515)?
Weekly Report · 05/18 10:22
Prestige Consumer Healthcare: Better Valuation, But Too Much Uncertainty To Buy
Seeking Alpha · 05/17 12:00
More
Webull provides a variety of real-time PBH stock news. You can receive the latest news about Prestige Consmr Healthcare Inc through multiple platforms. This information may help you make smarter investment decisions.
About PBH
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.